Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.
On January 24-26, 2013, the World Health Organization convened the first integrated meeting on "The development and clinical trials of vaccines that induce broadly protective and long-lasting immune responses" to review the current status of development and clinical evaluation of novel influenza vaccines as well as strategies to produce and deliver vaccines in novel ways. Special attention was given to the development of possible universal influenza vaccines. Other topics that were addressed included an update on clinical trials of pandemic and seasonal influenza vaccines in high-risk groups and vaccine safety, as well as regulatory issues.
['Girard|Marc P|MP|', 'Tam|John S|JS|', 'Pervikov|Yuri|Y|', 'Katz|Jacqueline M|JM|']
D000276:Adjuvants, Immunologic D000818:Animals D002986:Clinical Trials as Topic D006801:Humans D007252:Influenza Vaccines D007251:Influenza, Human D058873:Pandemics D014611:Vaccination D014613:Vaccines, Attenuated D014944:World Health Organization
Universal influenza vaccines Seasonal influenza vaccines Adjuvants Inactivated influenza vaccines Live attenuated influenza vaccines Neutralizing antibodies Pandemic influenza vaccines